Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-04-12, Stock:ABT, The news for the past five days is as follows:
2018-04-05: NEWS1: Edwards Lifesciences Gets CE Mark Approval for Its Centera Valve.NEWS2: Johnson & Johnson’s Business Segments in 2017.NEWS3: Varian’s HyperArc: Driven by Rising Metastatic Brain Cancer?.
2018-04-06: NEWS1: What’s behind Edwards Lifesciences’ Latest Valuation.
2018-04-09: NEWS1: New Trial Data Show Improved Clinical Outcomes with HeartMate3.NEWS2: MitraClip Drives Growth, Gets Reimbursement Approval in Japan.NEWS3: Abbott Initiates CardioMEMS HF System’s Clinical Trial.
2018-04-10: NEWS1: Abbott Laboratories Stock Performance in 1Q18.NEWS2: Will Buyouts Help Quest Diagnostics (DGX) Beat Q1 Earnings?.NEWS3: Will Buyouts Help Quest Diagnostics (DGX) Beat Q1 Earnings?.NEWS4: Ex-Dividend Reminder: PerkinElmer, Patterson Companies and Abbott Laboratories.NEWS5: Ex-Dividend Reminder: PerkinElmer, Patterson Companies and Abbott Laboratories.NEWS6: Abbott Laboratories Goes Ex-Dividend on April 12, 2018.NEWS7: Abbott’s Stock Price Momentum Continues: What’s Ahead?.NEWS8: See what the IHS Markit Score report has to say about Abbott Laboratories..NEWS9: Analysts’ Latest Recommendations and Target Prices for Abbott.
2018-04-11: NEWS1: Can Steady Overall Growth Drive Abbott's (ABT) Q1 Earnings?.NEWS2: Can Steady Overall Growth Drive Abbott's (ABT) Q1 Earnings?.NEWS3: Can Steady Overall Growth Drive Abbott&apos;s (ABT) Q1 Earnings?.NEWS4: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for April 12, 2018.NEWS5: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for April 12, 2018.NEWS6: Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease.NEWS7: Abbott’s Latest Valuation Metrics in April 2018.

Answer: Rise